
As an Amazon Associate and affiliate partner, Menrva Books earns from qualifying purchases. Learn more
Pink ribbon paraphernalia saturate shopping malls, billboards, magazines, television, and other venues, all in the name of breast cancer awareness. In this compelling and provocative work, Gayle Sulik shows that though this "pink ribbon culture" has brought breast cancer advocacy much attention, it has not had the desired effect of improving women's health. It may, in fact, have done the opposite. Based on eight years of research, analysis of advertisements and breast cancer awareness campaigns, and hundreds of interviews with those affected by the disease, Pink Ribbon Blues highlights the hidden costs of the pink ribbon as an industry, one in which breast cancer has become merely a brand name with a pink logo. Indeed, while survivors and supporters walk, run, and purchase ribbons for a cure, cancer rates rise, the cancer industry thrives, corporations claim responsible citizenship while profiting from the disease, and breast cancer is stigmatized anew for those who reject the pink ribbon model. But Sulik also outlines alternative organizations that make a real difference, highlights what they do differently, and presents a new agenda for the future.
Does the pervasive commercialization of breast cancer awareness, known as 'pink ribbon culture,' actually hinder meaningful progress in women's health outcomes? Gayle A. Sulik, a medical sociologist, utilizes eight years of rigorous research, including extensive interviews and an analysis of corporate marketing campaigns, to argue that the branding of breast cancer has prioritized corporate interests and superficial awareness over substantive medical research and patient support. She posits that this industry-driven model often obscures the complexities of the disease and marginalizes those who do not conform to the 'survivor' narrative.
What You Will Find
Experts in sociology and public health recognize this work as a critical examination of the intersection between corporate branding and medical advocacy. Readers frequently note the academic density of the prose and the author's meticulous documentation of the medical-industrial complex.
Page Count:
485
Publication Date:
2010-01-01
Publisher:
Oxford University Press
ISBN-10:
0199826579
ISBN-13:
9780199826575
No comments yet. Be the first to share your thoughts!